Patent · US Active

Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods

US7868034B2 · kind B2 · utility

0Cited by

14References

22Claims

0Family size

Assignee

H. LUNDBECK A/S · DK

Inventors

Michael Konkel · Fair Lawn, US
John M. Werzel · Fair Lawn, US
Jamie Talisman · New York, US

Key dates

Filing date	Jun 17, 2008
Grant date	Jan 11, 2011
Priority date	—
Expiry date	Nov 5, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention is directed to indolone derivatives which are antagonists or the GALR3 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.